blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3131572

EP3131572 - APC ANALOGUE FOR USE IN WOUND HEALING [Right-click to bookmark this link]
Former [2017/08]USE OF APC ANALOGUE FOR WOUND HEALING
[2020/32]
StatusNo opposition filed within time limit
Status updated on  20.05.2022
Database last updated on 08.04.2026
FormerThe patent has been granted
Status updated on  11.06.2021
FormerGrant of patent is intended
Status updated on  02.02.2021
FormerRequest for examination was made
Status updated on  11.12.2020
FormerGrant of patent is intended
Status updated on  02.08.2020
FormerRequest for examination was made
Status updated on  20.01.2017
FormerThe international publication has been made
Status updated on  31.10.2016
Most recent event   Tooltip19.12.2025Lapse of the patent in a contracting state
New state(s): TR		published on 21.01.2026  [2026/04]
Applicant(s)For all designated states
ZZ Biotech LLC
4265 San Felipe St. Suite 1100
Houston, TX 77027 / US
[2021/03]
Former [2017/08]For all designated states
ZZ Biotech LLC.
1001 McKinney, Suite 1900
Houston TX 77002 / US
Inventor(s)01 / XUE, Meilang
c/- The University of Sydney
Parramatta Road
New South Wales 2006 / AU
02 / JACKSON, Christopher John
c/- The University of Sydney
Parramatta Road
New South Wales 2006 / AU
 [2017/08]
Representative(s)Gregson, Anna Louise
Mathys & Squire The Shard
32 London Bridge Street
London SE1 9SG / GB
[2021/28]
Former [2017/08]Gregson, Anna Louise
Mathys & Squire LLP The Shard
32 London Bridge Street
London
SE1 9SG / GB
Application number, filing date15779573.316.04.2015
[2017/08]
WO2015AU50177
Priority number, dateAU2014090139716.04.2014         Original published format: AU 2014901397
AU2014090290025.07.2014         Original published format: AU 2014902900
[2017/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015157822
Date:22.10.2015
Language:EN
[2015/42]
Type: A1 Application with search report 
No.:EP3131572
Date:22.02.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 22.10.2015 takes the place of the publication of the European patent application.
[2017/08]
Type: B1 Patent specification 
No.:EP3131572
Date:14.07.2021
Language:EN
[2021/28]
Search report(s)International search report - published on:AU22.10.2015
(Supplementary) European search report - dispatched on:EP20.11.2017
ClassificationIPC:A61K38/48, A61P17/02
[2017/08]
CPC:
A61K38/4866 (EP,US); A61K9/0014 (EP,US); A61K9/0019 (US);
A61L26/0066 (EP,US); A61L26/0076 (EP,US); A61L26/008 (EP,US);
A61P17/02 (EP); A61L2300/252 (EP,US); C12Y304/21069 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/08]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:APC-ANALOGON ZUR VERWENDUNG IN DER WUNDHEILUNG[2020/32]
English:APC ANALOGUE FOR USE IN WOUND HEALING[2020/32]
French:ANALOGE D'APC POUR L'UTILISATION DANS LA CICATRISATION DES PLAIES[2020/32]
Former [2017/08]VERWENDUNG VON APC ZUR WUNDHEILUNG
Former [2017/08]USE OF APC ANALOGUE FOR WOUND HEALING
Former [2017/08]UTILISATION D'ANALOGE D'APC POUR LA CICATRISATION DES PLAIES
Entry into regional phase31.10.2016National basic fee paid 
31.10.2016Search fee paid 
31.10.2016Designation fee(s) paid 
31.10.2016Examination fee paid 
Examination procedure31.10.2016Examination requested  [2017/08]
31.10.2016Date on which the examining division has become responsible
01.06.2018Amendment by applicant (claims and/or description)
03.08.2020Communication of intention to grant the patent
10.12.2020Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
03.02.2021Communication of intention to grant the patent
02.06.2021Fee for grant paid
02.06.2021Fee for publishing/printing paid
02.06.2021Receipt of the translation of the claim(s)
Opposition(s)19.04.2022No opposition filed within time limit [2022/25]
Fees paidRenewal fee
21.04.2017Renewal fee patent year 03
23.04.2018Renewal fee patent year 04
23.04.2019Renewal fee patent year 05
30.03.2020Renewal fee patent year 06
29.04.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.04.2015
AL14.07.2021
CY14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
MK14.07.2021
MT14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
TR14.07.2021
BG14.10.2021
IS14.11.2021
LU16.04.2022
[2026/04]
Former [2024/41]HU16.04.2015
AL14.07.2021
CY14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
MK14.07.2021
MT14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
LU16.04.2022
Former [2024/22]HU16.04.2015
AL14.07.2021
CY14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
MK14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
LU16.04.2022
Former [2024/20]HU16.04.2015
AL14.07.2021
CY14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
LU16.04.2022
Former [2024/18]HU16.04.2015
AL14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
LU16.04.2022
Former [2023/08]AL14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
LU16.04.2022
Former [2023/06]AL14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
MC14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
Former [2022/29]AL14.07.2021
EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
RO14.07.2021
RS14.07.2021
SI14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
Former [2022/26]EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
RO14.07.2021
RS14.07.2021
SK14.07.2021
SM14.07.2021
BG14.10.2021
IS14.11.2021
Former [2022/24]EE14.07.2021
HR14.07.2021
LT14.07.2021
LV14.07.2021
RO14.07.2021
RS14.07.2021
SK14.07.2021
BG14.10.2021
IS14.11.2021
Former [2022/12]HR14.07.2021
LT14.07.2021
LV14.07.2021
RS14.07.2021
BG14.10.2021
IS14.11.2021
Former [2022/09]LT14.07.2021
RS14.07.2021
BG14.10.2021
Former [2022/08]LT14.07.2021
BG14.10.2021
Documents cited:Search[XD] WO2008073603  (SCRIPPS RESEARCH INST et al.) [XD] 1-8 * paragraph [0023]; claim - *
International search[X] US2013280234  (JACKSON CHRISTOPHER JOHN et al.) [X] 1-8 * Abstract; [0002]; [0017]-[0026]; [0016]; [0030]; [0034]; [0036] *
 [X] WO2014005183  (UNIV SYDNEY et al.) [X] 1-8 * Abstract; page 5 lines 1-3; page 11 lines 1-9; page 15 lines 12-24; page 18 lines 1-9 *
 [A] WO2005007820  (SCRIPPS RESEARCH INST et al.) [A] 1-8 * Abstract; [0048]; [0042] *
 [X]   MC KELVEY K ET AL.: "Activated Protein C: A regulator of numan epidermal keratinocyte function", WORLD J BIOL CHEM, vol. 5, no. 2, 26 May 2014 (2014-05-26), pages 169 - 179, XP055233306 [X] 1-8 * . Abstract; page 175 column 1 pagaragraph 4; page 174 column 1 last paragraph-page 174 column 2 *

DOI:   http://dx.doi.org/10.4331/wjbc.v5.i2.169
 [A]   WILLIAMS PD ET AL.: "Preclinical Safety and Pharmacokinetic Profile of 3K3-APC, a Novel, Modified Activated Protein C for Ischemic Stroke", CURR PHARM DES., vol. 18, no. 27, 2012, pages 4215 - 4222, XP055233307 [A] 1-8 * . Abstract; Introduction at paragraphs 5-6; Discussion; Conclusion *
 [A]   WALKER CT ET AL.: "Activated protein C with reduced anticoagulant activity improves functional recovery and reduces bleeding risk following controlled cortical impact", BRAIN RES, vol. 1347, 2010, pages 125 - 131, XP027164200, ISSN: 0006-8993 [A] 1-8 * . Abstract; Section 2.2-2.3 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.